Skip to main content
. 2019 May 7;25(9):995–1005. doi: 10.1111/cns.13142

Figure 1.

Figure 1

Changes induced by DMF treatment on T‐ and B‐lymphocyte subpopulations. Representation of percentages (%) of central memory (CCR7+ CD45RA), effector memory (CCR7 CD45RA), and naïve (CCR7+ CD45RA+) subpopulations from CD4+ and CD8+ T lymphocytes (A and B, respectively); and % of preswitched memory (CD27+ IgD+), class‐switched (CD27+ IgD) and (CD27 IgD+) naïve CD19+ B lymphocytes (C), before the treatment (baseline) and after 1, 3, 6 and, 12 months of follow‐up. Data are expressed as mean SD. Each dot represents the value of an individual (n = 22). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001